Cashu FinanceCashu Finance
  • Terminal
  • Spotlight
  • Cashu Research
Log inSign Up
← Back to Terminal
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. CODX

Market Cap: $3.82M

CI

Co-Diagnostics, Inc.

CODX
NASDAQUSD
Purchase CODX
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutive
Cashu FinanceCashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Research is part of Cashu Technology Pty Ltd, which is an authorised representative (AR # 001318029) of Adviser Solutions Group Pty Ltd (ABN 88 601 875 521) (AFSL 485946) (ASG).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by Cashu Technologies Pty Ltd, any of their related body corporates or any other person. To the maximum extent possible, Cashu Technologies Pty Ltd, their related body corporates or any other person do not accept any liability for any statement in this material.

–
–(–)

Open

$3.02

Prev. Close

$0.5455

High

$3.02

Low

$2.71

Company Profile

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.

CEODwight Egan
Sector

Recently from Cashu

CoDiagnostics Advances with Manufacturing Facility in Saudi Arabia's Molecular Diagnostics Landscape

CoDiagnostics Expands its Footprint in Saudi Arabia's Molecular Diagnostics Sector CoDiagnostics, Inc., through its joint venture CoMira Diagnostics, marks a significant milestone with the recent allo…

Cashu Finance·7 months ago

CoDiagnostics Innovates TB Testing with New PCR-based Solutions and Clinical Studies Launch

CoDiagnostics Advances Tuberculosis Testing with Innovative Solutions CoDiagnostics, Inc. is set to enhance tuberculosis (TB) diagnostic capabilities through the anticipated launch of clinical perform…

Cashu Finance·7 months ago

CoSara Innovates Healthcare in India with Localized Diagnostic Solutions and Expansion Plans

CoSara Aims to Transform Healthcare with Advanced Diagnostic Solutions in India CoSara, the joint venture between Co-Diagnostics, Inc. (Co-Dx) and Ambalal Sarabhai Enterprises Limited, is poised to re…

Cashu Finance·7 months ago

CoDiagnostics Showcases Innovations at Medical Korea 2026 to Expand Global Presence

CoDiagnostics Strengthens International Presence at Medical Korea 2026 CoDiagnostics, Inc., a leader in molecular diagnostics, prepares to showcase its innovative diagnostic solutions at Medical Korea…

Cashu Finance·7 months ago
Healthcare
IndustryBiotechnology
Employees115
IPO DateJul 12, 2017
ExchangeNASDAQ
Exchange NameNASDAQ
CurrencyUSD
Headquarters & Contact
Address2401 S. Foothill Dr.
City / State / ZIPSalt Lake City, UT, 84109
CountryUnited States
Phone801 438 1036
Websitehttps://co-dx.com